Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1

被引:49
|
作者
Karagiannis, George S. [1 ,2 ]
Berk, Aaron [1 ]
Dimitromanolakis, Apostolos [2 ]
Diamandis, Eleftherios P. [1 ,2 ,3 ]
机构
[1] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[2] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5T 3L9, Canada
[3] Univ Hlth Network, Dept Clin Biochem, Toronto, ON, Canada
来源
MOLECULAR ONCOLOGY | 2013年 / 7卷 / 04期
关键词
Colorectal cancer; Cancer-associated fibroblasts; Desmoplasia; Bone morphogenetic protein; Gremlin-1; Migration; STEM-CELL NICHE; MATHEMATICAL-MODEL; TUMOR-GROWTH; MESENCHYMAL TRANSITION; DUAL ROLE; TGF-BETA; FIBROBLASTS; GENE; EXPRESSION; SUPPRESSION;
D O I
10.1016/j.molonc.2013.04.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The cancer invasion front (OF), a spatially-recognized area due to the frequent presence of peritumoral desmoplastic reaction, represents a cancer site where many hallmarks of cancer metastasis occur. It is now strongly suggested that the desmoplastic microenvironment holds crucial information for determining tumor development and progression. Despite extensive research on tumor-host cell interactions at CIFs, the exact paracrine molecular network that is hardwired into the proteome of the stromal and cancer subpopulations remains partially understood. Here, we interrogated the signaling pathways and the molecular functional signatures across the proteome of a desmoplastic coculture model system of colorectal cancer progression. We discovered a group of bone morphogenetic protein (BMP) antagonists that coordinates major biological programs in CIFs, including cell proliferation, invasion, migration and differentiation processes. Using a mathematical model of cancer cell progression, coupled to in vitro cell migration assays, we demonstrated that the prominent BMP antagonist gremlin-1 (GREM1) may trigger motility of cancer cell cohorts. Our data collectively demonstrate that the desmoplastic CIFs deploy a microenvironmental signature, based on BMP antagonism, in order to regulate the motogenic fates of cancer cell cohorts invading the adjacent stroma. (C) 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:826 / 839
页数:14
相关论文
共 23 条
  • [1] Bone morphogenetic protein antagonist gremlin-1 regulates colon cancer progression
    Karagiannis, George S.
    Musrap, Natasha
    Saraon, Punit
    Treacy, Ann
    Schaeffer, David F.
    Kirsch, Richard
    Riddell, Robert H.
    Diamandis, Eleftherios P.
    BIOLOGICAL CHEMISTRY, 2015, 396 (02) : 163 - 183
  • [2] Insights into the Role of Gremlin-1, a Bone Morphogenic Protein Antagonist, in Cancer Initiation and Progression
    Elemam, Noha Mousaad
    Malek, Abdullah Imadeddin
    Mahmoud, Esraa Elaraby
    El-Huneidi, Waseem
    Talaat, Iman M.
    BIOMEDICINES, 2022, 10 (02)
  • [3] Alveolar Macrophages Express the Bone Morphogenetic Protein Antagonist Gremlin-1
    Thong, L.
    O'Driscoll, M.
    Casey, C.
    Kennedy, M.
    Plant, B. J.
    Henry, M. T.
    Murphy, D. M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : S493 - S493
  • [4] Macrophages Increase the Bone Morphogenetic Protein Antagonist Gremlin-1 in Response to Hypoxia
    Mthunzi, L.
    Knaus, U.
    McLoughlin, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [5] Hypoxia induces alternative activation of macrophages and increases their expression of the bone morphogenetic protein antagonist gremlin-1
    Chong, S. G.
    Nadarajan, P.
    Fabre, A.
    Kane, R.
    Keane, M. P.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S405 - S405
  • [6] Hypoxia induces alternative activation ofmacrophages and increases their expression of the bone morphogenetic protein antagonist gremlin-1
    Mthunzi, L.
    Kubica, M.
    Knaus, U.
    McLoughlin, P.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 (SUPPL 10) : S405 - S405
  • [7] Bone Morphogenetic Protein Antagonist Gremlin-1 Increases Myofibroblast Transition in Dermal Fibroblasts: Implications for Systemic Sclerosis
    Duffy, Laura
    Henderson, John
    Brown, Max
    Pryzborski, Stefan
    Fullard, Nicola
    Summa, Lena
    Distler, Jorg H. W.
    Stratton, Richard
    O'Reilly, Steven
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [8] Expression patterns of bone morphogenetic protein antagonists in colorectal cancer desmoplastic invasion fronts
    Karagiannis, George S.
    Treacy, Ann
    Messenger, David
    Grin, Andrea
    Kirsch, Richard
    Riddell, Robert H.
    Diamandis, Eleftherios P.
    MOLECULAR ONCOLOGY, 2014, 8 (07) : 1240 - 1252
  • [9] Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation
    Sneddon, Julie B.
    Zhen, Hanson H.
    Montgomery, Kelli
    van de Rijn, Matt
    Tward, Aaron D.
    West, Robert
    Gladstone, Hayes
    Chang, Howard Y.
    Morganroth, Greg S.
    Oro, Anthony E.
    Brown, Patrick O.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (40) : 14842 - 14847
  • [10] Bone morphogenetic protein antagonist DMH1 inhibits metastasis in a mouse model of breast cancer
    Owens, Philip
    Pickup, Michael W.
    Gorska, Agnieszka E.
    Novitskiy, Sergey V.
    Hong, Charles C.
    Moses, Harold L.
    CANCER RESEARCH, 2013, 73